Caplight Directory>Companies>Leman Biotech-preview>Lemanbio


Leman Biotech

Leman Biotech

Private
ShenzhenN/Ahttps://lemanbio.com/

Last Round

Series A

Extension

Mar 4, 2026

Total Funding Raised

$60M

Momentum Score

25 /100

Company Overview

Leman Biotech is a biotechnology company that develops next-generation metabolic cancer immunotherapies.

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Leman Biotech Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Leman Biotech Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series A ExtensionMar 4, 2026
Series ANov 13, 2024
AngelJun 18, 2024
AngelJan 18, 2022
View all Funding Rounds

Leman Biotech Investors

Notable investors and investment history

InvestorRounds
中山创业投资有限公司Series A Extension
Fuhui Venture CapitalAngel
Tiantu CapitalAngel
Tailong InvestmentSeries A Extension
5Y CapitalAngel
Zhongshan Venture Capital Co., Ltd.Series A Extension
Yuecai Zhongyin Private Equity Fund ManagementSeries A Extension
View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 4, 2026

    $28M round led by XtalPi and Yuecai Zhongyin.

  • Nov 7, 2025

    Monthly visitors increased 31% MoM.

View all signals

Leman Biotech Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Leman Biotech Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Leman Biotech's valuation, stock price, and market status.

Firmographic Details

HeadquartersShenzhen
Employee Range3
Year Founded2021
Last FundingMar 4, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.